CN Patent

CN101687857A — 嘧啶基哒嗪酮衍生物

Assigned to Merck Patent GmbH · Expires 2010-03-31 · 16y expired

What this patent protects

选自权利要求1的化合物组的化合物是酪氨酸激酶、尤其是Met激酶的抑制剂，能用于治疗尤其是肿瘤。

USPTO Abstract

选自权利要求1的化合物组的化合物是酪氨酸激酶、尤其是Met激酶的抑制剂，能用于治疗尤其是肿瘤。

Drugs covered by this patent

tepotinib-hydrochloride (TEPOTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN101687857A
Jurisdiction: CN
Classification: —
Expires: 2010-03-31
Drug substance claim: No
Drug product claim: No
Assignee: Merck Patent GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.